SCHEMBL6003653

SCHEMBL6003653

COc1cc(Cc2cncnc2)c2cc(Cc3c[nH]c4cc(F)ccc34)oc2c1OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 2/20 0.42
SSTR4 P31391 10/20 0.41
SSTR2 P30874 7/20 0.41
SSTR1 P30872 7/20 0.39
SSTR3 P32745 7/20 0.39
PDGFRB P09619 1/20 0.37
TUBB4A P04350 2/20 0.36
TUBB P07437 2/20 0.36
TUBA3C P0DPH7 2/20 0.36
TUBA1B P68363 2/20 0.36
TUBA4A P68366 2/20 0.36
TUBB4B P68371 2/20 0.36
TUBB3 Q13509 2/20 0.36
TUBB2A Q13885 2/20 0.36
TUBB8 Q3ZCM7 2/20 0.36
TUBA3E Q6PEY2 2/20 0.36
TUBA1A Q71U36 2/20 0.36
TUBA1C Q9BQE3 2/20 0.36
TUBB6 Q9BUF5 2/20 0.36
TUBB2B Q9BVA1 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3246894 0.82 DHFR (0.44) GPR84
SCHEMBL6004526 0.80 TUBB4A (0.44) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL3246827 0.70 DHFR (0.46)
SCHEMBL5659886 0.68 GPR55 (0.46) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL3250264 0.67 MTNR1A (0.47) GPR84
SCHEMBL3254525 0.66 DHFR (0.45)
SCHEMBL5657385 0.66 DHFR (0.53)
Hydrochloric Acid SCHEMBL5660314 0.66 DHFR (0.52)
SCHEMBL31744568 0.64 SSTR1 (0.61) GPR84SSTR4SSTR2SSTR1SSTR3
SCHEMBL27929607 0.64 GPR84 (1.00) GPR84SSTR4SSTR2SSTR1SSTR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1651639-A1 BENZOFURAN DERIVATIVES AND THEIR USE IN THE TREATMENT OF MICROBIAL INFECTIONS Arpida AG, (CH) 2006-05-03 EP disclosed
WO-2005005418-A1 BENZOFURAN DERIVATIVES AND THEIR USE IN THE TREATMENT OF MICROBIAL INFECTIONS ARPIDA AG (CH) 2005-01-20 WO disclosed